Highlight
No significant differences in postoperative complications were found based on the interval between completion of postmastectomy radiotherapy (PMRT) and autologous breast reconstruction (ABR).
The timing intervals analyzed included 0-3, 3-6, 6-12, and over 12 months post-PMRT.
Comparable rates of flap failure, thrombosis, infection, reoperation, and wound complications were observed between PMRT and non-PMRT groups.
The findings challenge the traditional delay approach often recommended after radiotherapy before proceeding with ABR.
Study Background
Breast reconstruction following mastectomy, particularly autologous breast reconstruction (ABR), plays a critical role in restoring body image and psychological well-being for patients with breast cancer. Postmastectomy radiotherapy (PMRT) is often indicated to reduce locoregional recurrence risk but introduces challenges for reconstruction due to radiation-induced tissue damage. Traditionally, ABR is delayed for several months after PMRT to allow radiation effects to subside and to minimize postoperative complications such as flap failure, necrosis, infection, and wound healing problems. However, the optimal timing interval between PMRT completion and ABR remains poorly defined, with varying clinical practice based on institutional protocols and surgeon preference.
Understanding the safest and most effective timing for ABR after PMRT is crucial, as delays may negatively impact patient quality of life and increase healthcare utilization, while premature reconstruction risks heightened complications. This study addresses a significant knowledge gap by systematically analyzing the postoperative outcomes relative to the timing of ABR and PMRT.
Study Design
This retrospective cohort study included 339 adult female patients undergoing ABR, cumulatively contributing 514 flaps. Patients were divided based on whether they received PMRT prior to reconstruction. The PMRT group was further stratified by timing from PMRT completion to ABR into four intervals: 0-3 months, 3-6 months, 6-12 months, and over 12 months.
Primary outcomes measured were flap failure or necrosis and immediate reoperation rates. Secondary outcomes included other complications such as infection, wound dehiscence, flap thrombosis, and operative time. Statistical analyses included chi-squared and Fisher exact tests for categorical variables, Kruskal-Wallis and Wilcoxon rank sum tests for continuous variables, alongside a logistic mixed-effects model to account for confounding variables and repeated measures from multiple flaps per patient.
Key Findings
The study found that 37.2% of ABR flaps were performed after PMRT across the four timing cohorts as follows: 5 flaps within 0-3 months, 72 within 3-6 months, 71 within 6-12 months, and 43 beyond 12 months. Despite clinical assumptions, no statistically significant differences were detected in the rates of flap failure, thrombosis, infection, wound dehiscence, reoperation, or operative duration when comparing flaps performed after PMRT versus those without PMRT. Furthermore, no significant differences emerged among the different PMRT-to-ABR timing intervals.
The logistic mixed-effects model similarly failed to identify an association between the timing interval and postoperative complications, supporting the primary analyses findings.
Interestingly, even the earliest group (0-3 months post-PMRT), traditionally considered higher risk due to acute radiation effects, did not demonstrate increased adverse outcomes, though this group was small (n=5 flaps) which limits statistical power.
Expert Commentary
These findings challenge the dogma that substantial delay between PMRT and ABR is mandatory to reduce complications. The absence of measurable adverse effects related to earlier reconstruction timing suggests that patient-specific risk factors, surgical technique, and institutional expertise may be more influential determinants of outcomes than timing alone.
Radiation exerts complex effects on tissue microvasculature, inflammation, and fibrosis. Hence, biological plausibility exists for delayed surgery; however, modern advances in microsurgical technique, perioperative care, and radiation delivery may mitigate these risks. This study’s robust methodology and relatively large sample size lend weight to these observations.
Limitations include its retrospective design and possible selection bias, especially for the earliest post-PMRT group due to small sample size. Furthermore, variables such as radiation dosage, mastectomy type, flap type, patient comorbidities, and smoking status that impact outcomes require granular evaluation.
Current guidelines remain variable; this data suggests flexibility may be warranted, with decisions tailored to individual clinical scenarios rather than arbitrary waiting periods. Prospective studies and randomized trials would be valuable to confirm these findings and guide protocol development.
Conclusion
This study provides evidence that timing of autologous breast reconstruction after postmastectomy radiotherapy, whether performed within 3 months or more than a year after radiation, does not significantly affect surgical complication rates. These results suggest that stringent delay intervals may not be universally necessary, offering potential for earlier reconstruction to improve patient-centered outcomes without increasing risk.
Clinicians should consider comprehensive patient assessment, surgical expertise, and institutional factors when planning reconstruction timing. Further prospective research will help refine guidelines and optimize recovery pathways for breast cancer survivors requiring reconstructive surgery.
Funding and Registration
The original publication did not report specific funding sources or clinical trial registration identifiers.
References
1. Dadzie AI, Rossman A, Hansen K, et al. An Analysis of the Timing of Autologous Breast Reconstruction after Mastectomy and Radiotherapy. Plast Reconstr Surg. 2026;158(5):755e-764e. doi:10.1097/PRS.0000000000009761
2. Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg. 2009;124(2):395-408.
3. Cordeiro PG. Breast reconstruction after surgery for breast cancer. N Engl J Med. 2008;359(15):1590-1601.
4. Cordeiro PG, Mahmood U, McCarthy CM, et al. Timing of postmastectomy radiation therapy with tissue expander exchange and autologous reconstruction. Plast Reconstr Surg. 2017;140(3):450-458.
5. Nahabedian MY. Impact of radiation therapy on breast reconstruction. Microsurgery. 2012;32(7):522-529.
